Carus Animal Health has launched a free educational booklet for veterinary professionals on the use of faecal calprotectin in feline medicine.

Bringing together the latest research, practical guidance and case studies, the resource is designed to help veterinary teams managing chronic gastrointestinal (GI) disease in cats.

Carus says that while faecal calprotectin is well established in human medicine, the veterinary evidence base in cats continues to build.

The publication includes findings from a University of Bristol validation study demonstrating that the GIQuest faecal calprotectin test differentiated cats with chronic inflammatory enteropathy from healthy controls with 100% specificity and 92% sensitivity.

The booklet also features case studies from UK veterinary professionals, illustrating how faecal calprotectin testing has been used to support diagnosis, monitor treatment response and identify inflammatory flare-ups in complex chronic GI cases.

Lucy Williams BVSc MRCVS, Marketing and Veterinary Technical Services Manager at Carus Animal Health, said: "Feline gastrointestinal disease can be particularly challenging to manage.

"Clinical signs are often non-specific, diagnostics can be limited by patient temperament or owner factors, and monitoring treatment response isn't always straightforward.

"The growing evidence around faecal calprotectin is exciting because it offers clinicians an objective measure of intestinal inflammation that can support decision-making throughout the patient journey."

https://content.carusanimalhealth.com/feline-only-booklet-download